A61K 31/4965
Non-condensed pyrazines
A61K31/4965 (Non-condensed pyrazines) appears on 2,475 US grants and 4,675 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,475
- Published applications
- 4,675
- Assignees
- 1,628
- Inventors
- 10,927
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 4 | 0 |
| 1997 | 8 | 0 |
| 1998 | 8 | 0 |
| 1999 | 9 | 0 |
| 2000 | 10 | 0 |
| 2001 | 13 | 6 |
| 2002 | 20 | 32 |
| 2003 | 19 | 59 |
| 2004 | 16 | 74 |
| 2005 | 23 | 85 |
| 2006 | 39 | 85 |
| 2007 | 29 | 87 |
| 2008 | 30 | 119 |
| 2009 | 31 | 104 |
| 2010 | 47 | 129 |
| 2011 | 43 | 153 |
| 2012 | 65 | 127 |
| 2013 | 112 | 206 |
| 2014 | 152 | 271 |
| 2015 | 177 | 241 |
| 2016 | 186 | 258 |
| 2017 | 180 | 264 |
| 2018 | 179 | 259 |
| 2019 | 180 | 251 |
| 2020 | 163 | 239 |
| 2021 | 156 | 248 |
| 2022 | 125 | 220 |
| 2023 | 136 | 299 |
| 2024 | 110 | 295 |
| 2025 | 122 | 320 |
| 2026 | 83 | 244 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods comprising endothelin a receptor antagonists and androgen therapies29 Sep 2026US 12,746,239 B2The United States Government as represented by the Department of Veterans Affairs
- LOX enzyme inhibiting methods and compositions29 Sep 2026US 12,746,243 B2Anovia Biosciences, Inc.
- Heterocyclic compounds for the control of invertebrate pests22 Sep 2026US 12,740,561 B2BASF SE
- Methods and compositions for treating cancer22 Sep 2026US 12,740,976 B2City of Hope
- Methods of treating ischemic disease by administering an ATR kinase inhibitor22 Sep 2026US 12,740,980 B2East Tennessee State University Research Foundation
- Methods of preventing post-traumatic osteoarthritis using metformin8 Oct 2026US 2026/0306428 A1
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Combination therapy for pulmonary hypertension8 Oct 2026US 2026/0306461 A1Vivus, Inc.
- Inverse agonists of rar related orphan receptors (rors)8 Oct 2026US 2026/0306484 A111949098 CANADA INC. (NUREDCO) c/o Jean I. TCHERVENKOV
- Cis-8-(3,5-Difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives8 Oct 2026US 2026/0308140 A1Gruenenthal GmbH
Most cited
By later US patents
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Penetrating pharmaceutical foam145US 7,700,076 B2Foamix Ltd. · 2010
- Pyrazole compound and medicinal composition containing the same142US 7,429,609 B2Eisai R&D Management Co., Ltd. · 2008
- Pyrazole compositions useful as inhibitors of ERK126US 6,784,195 B2Vertex Pharmaceuticals Incorporated · 2004
- Modulators of ATP-binding cassette transporters124US 7,659,268 B2Vertex Pharmaceuticals Incorporated · 2010